RFK Just Declared War on Antidepressants. He’s Not Wrong About Everything.
The Headline You May Have Missed
Yesterday, Health Secretary Robert F. Kennedy Jr. , the top health official in the United States , announced a sweeping set of initiatives aimed at reducing America’s dependence on antidepressants, specifically SSRIs, the most widely prescribed class of psychiatric medications in the country. The announcement came at a Mental Health and Overmedicalization Summit and included new clinical guidelines, reimbursement mechanisms for doctors who help patients taper off medications, and training modules focused on non-pharmaceutical interventions.
Love him or hate him , and plenty of people do both , Kennedy is drawing attention to something real.
The Numbers Are Hard to Ignore
In 2025, 16.6 percent of U.S. adults , roughly one in six Americans , reported currently taking an SSRI. That’s Zoloft, Lexapro, Paxil, Prozac. First introduced nearly 40 years ago, these medications surged in popularity because they had fewer side effects than previous antidepressants and could be prescribed by a general practitioner , not just a psychiatrist.
That last part matters. A lot of people on SSRIs were never seen by a mental health professional. They went to their GP, described feeling anxious or low, and left with a prescription. That’s not a conspiracy. That’s just what happens when demand for mental health care far exceeds the supply of people trained to deliver it.
Let’s Be Clear About What This Is and Isn’t
SSRIs save lives. For people with clinical depression, severe anxiety disorders, OCD, and PTSD, these medications can be genuinely transformative. Anyone currently taking an SSRI should not stop without working closely with their physician. Full stop.
Kennedy is a controversial figure and some of his claims , including comparing SSRI withdrawal to heroin , go well beyond what the evidence supports. Major psychiatric organizations have pushed back, and that pushback is legitimate.
But here is where the conversation gets interesting.
Kennedy’s core observation , that psychiatric medications have become the default rather than one option among many , is not fringe. It is a concern that has been quietly shared by clinicians, researchers, and patients for years. A 2019 study found that 56 percent of patients experienced withdrawal symptoms when stopping antidepressants. The system was not built to support them through that process. Kennedy’s new reimbursement mechanisms , paying doctors for time spent helping patients taper off medications , are actually a reasonable policy response to a real problem.
The Gap Nobody Is Talking About
Here is what the debate around Kennedy’s announcement is missing entirely.
The conversation keeps circling between two options: medicate or don’t medicate. Take the SSRI or white-knuckle it. But there is an enormous population of people who fall between those two poles , people experiencing chronic low-grade anxiety, stress, emotional dysregulation , who don’t need clinical intervention but desperately need something better than what they’re currently doing.
What are they currently doing? They’re having a glass of wine to decompress. They’re scrolling for three hours. They’re managing. Barely.
That gap , between people who need a psychiatrist and people who just need a better daily ritual , is where we built SoulBloom.
What SoulBloom Is and Isn’t
SoulBloom is not a replacement for psychiatric medication. We want to be unambiguous about that. If you are managing a clinical condition with the support of a physician, that conversation is between you and your doctor , not us.
What SoulBloom is, is a physician-crafted botanical supplement built around kanna , an empathogenic plant from Southern Africa that has been used for centuries to promote calm, ease social anxiety, and support emotional balance. Our formulas were developed by a practicing physician who spent a year off alcohol and went looking for something better.
Important: Kanna works on serotonin pathways, which means it is contraindicated with SSRIs, SNRIs, and MAOIs. That is a hard line for us and we state it clearly everywhere. If you are currently on any of these medications, SoulBloom is not for you.
But for the person who is not on psychiatric medication, who is not in clinical distress, who is simply running on empty and reaching for the wrong tools , SoulBloom was built for that person.
The Bigger Picture
Whether you agree with Kennedy’s politics or not, this moment is forcing a conversation America has been avoiding. We over-indexed on pharmaceutical solutions without building the infrastructure to support people in or out of them. We normalized self-medication through alcohol without acknowledging what that costs. We optimized productivity and forgot to give people a way to actually exhale.
That is the crisis. And it is bigger than any one politician or any one supplement.
But it does create an opening , for honest conversation, for better options, and for the kind of physician-led guidance that has been missing from the wellness space for too long. That is the conversation SoulBloom is here to have.
“I spent a year trying to find something honest in the wellness space. Something with a real mechanism, a clean safety profile, and a physician willing to put their name on it. That’s what we built. Not because the market needed another supplement. Because the gap was real and nobody was filling it right.”, Dr. Marhamati
Find Your Alternative
Two Blends. One Honest Answer.
Radiance for the social moment. Harmony for the wind-down.
Why This Matters to SoulBloom
SoulBloom exists in the space Kennedy’s announcement just made visible. We are not here for the clinical conversation , that belongs to physicians and psychiatrists. We are here for the 50 million Americans who are not in crisis but are not okay either. Who are using alcohol, screens, and sugar to manage a nervous system that never gets to rest.
Kanna is not a drug. It is not a medication. It is a plant that has been used for centuries, that has a studied mechanism, and that we formulated with the care the category deserves. That is the standard this moment demands.
SoulBloom is here.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. SoulBloom products are contraindicated with SSRIs, SNRIs, and MAOIs. Consult your healthcare provider before starting any supplement, particularly if you are taking psychiatric medication.